237 related articles for article (PubMed ID: 6175048)
1. Plasma beta-thromboglobulin and platelet factor 4 in patients with chronic renal failure and effect of hemodialysis.
Endo Y; Mamiya S; Satoh M; Takahashi K; Harada T
Tohoku J Exp Med; 1981 Dec; 135(4):349-58. PubMed ID: 6175048
[TBL] [Abstract][Full Text] [Related]
2. Platelet factor 4 (PF4) and heparin-released platelet factor 4 (HR-PF4) in patients with cardiovascular disorders.
Cella G; Colby SI; Taylor AD; McCracken L; Parisi AF; Sasahara AA
Thromb Res; 1983 Mar; 29(5):499-509. PubMed ID: 6222505
[TBL] [Abstract][Full Text] [Related]
3. [Clinical significance of the radioimmunological determination of beta-thromboglobulin and platelet factor 4].
Schernthaner G; Silberbauer K; Mühlhauser I; Willvonseder R
Acta Med Austriaca Suppl; 1979; 6():375-9. PubMed ID: 95543
[TBL] [Abstract][Full Text] [Related]
4. Effects of pressure excursions on human platelets. In vitro studies on betathromboglobulin (beta-TG) and platelet factor 4 (PF4) release and on platelet sensitivity to ADP-aggregation.
Torsellini A; Becucci A; Citi S; Cozzolino F; Guidi G; Lombardi V; Vercelli D; Veloci M
Haematologica; 1982; 67(6):860-6. PubMed ID: 6186580
[No Abstract] [Full Text] [Related]
5. A radioimmunoassay for thrombospondin, used in a comparative study of thrombospondin, beta-thromboglobulin and platelet factor 4 in healthy volunteers.
Dawes J; Clemetson KJ; Gogstad GO; McGregor J; Clezardin P; Prowse CV; Pepper DS
Thromb Res; 1983 Mar; 29(6):569-81. PubMed ID: 6190242
[TBL] [Abstract][Full Text] [Related]
6. Secreted platelet proteins with antiheparin and mitogenic activities in chronic renal failure.
Guzzo J; Niewiarowski S; Musial J; Bastl C; Grossman RA; Rao AK; Berman I; Paul D
J Lab Clin Med; 1980 Jul; 96(1):102-13. PubMed ID: 6446588
[TBL] [Abstract][Full Text] [Related]
7. Reduction of plasma levels of betathromboglobulin and platelet factor 4 during hemodialysis: a possible role for a short acting inhibitor of platelet aggregation.
Buccianti G; Pogliani E; Miradoli R; Colombi MA; Valenti G; Lorenz M; Polli EE
Clin Nephrol; 1982 Oct; 18(4):204-8. PubMed ID: 6183040
[TBL] [Abstract][Full Text] [Related]
8. beta-thromboglobulin (beta-TG) and platelet factor 4 (PF4) in obstetrical cases.
Arocha-Piñango CL; Ojeda A; López G; García L; Linares J
Acta Obstet Gynecol Scand; 1985; 64(2):115-20. PubMed ID: 2580418
[TBL] [Abstract][Full Text] [Related]
9. Role of kidney in the catabolic clearance of human platelet antiheparin proteins from rat circulation.
Bastl CP; Musial J; Kloczewiak M; Guzzo J; Berman I; Niewiarowski S
Blood; 1981 Feb; 57(2):233-8. PubMed ID: 6160892
[TBL] [Abstract][Full Text] [Related]
10. Does the beta-TG/PF4 ratio have any value?
Arocha-Piñango CL; Ojeda A
Thromb Haemost; 1983 Apr; 49(2):147. PubMed ID: 6191402
[No Abstract] [Full Text] [Related]
11. Studies of beta-thromboglobulin, platelet factor 4, and fibrinopeptide A in erythrocytosis due to cyanotic congenital heart disease.
Rosove MH; Hocking WG; Harwig SS; Perloff JK
Thromb Res; 1983 Jan; 29(2):225-35. PubMed ID: 6189239
[TBL] [Abstract][Full Text] [Related]
12. Are platelet factor 4 and beta-thromboglobulin markers of cardiovascular disorders?
Cella G; Scattolo N; Girolami A; Sasahara AA
Ric Clin Lab; 1984; 14(1):9-18. PubMed ID: 6203164
[TBL] [Abstract][Full Text] [Related]
13. [Clinical applications of beta-thromboglobulin and platelet factor 4 radioimmune assays (author's transl)].
Lokiec F; Najean Y
Nouv Presse Med; 1980 Oct; 9(38):2833-4, 2837-8. PubMed ID: 6160454
[TBL] [Abstract][Full Text] [Related]
14. Plasma levels of beta-thromboglobulin and platelet factor 4 in relation to the venous platelet concentration.
Kutti J; Safai-Kutti S; Zaroulis CG; Good RA
Acta Haematol; 1980; 64(1):1-5. PubMed ID: 6158243
[TBL] [Abstract][Full Text] [Related]
15. The release of beta-thromboglobulin and platelet factor 4 during extracorporeal circulation for open heart surgery.
Cella G; Vittadello O; Gallucci V; Girolami A
Eur J Clin Invest; 1981 Jun; 11(3):165-9. PubMed ID: 6168469
[TBL] [Abstract][Full Text] [Related]
16. Plasma concentrations of plbatelet-specific proteins in coronary artery disease.
Mühlhauser I; Schernthaner G; Silberbauer K; Sinzinger H; Kaindl F
Cardiology; 1981; 68(3):129-38. PubMed ID: 6172197
[TBL] [Abstract][Full Text] [Related]
17. Heparin-releasable platelet factor 4 in patients with coronary artery disease.
Sadayasu T; Nakashima Y; Yashiro A; Kawashima T; Kuroiwa A
Clin Cardiol; 1991 Sep; 14(9):725-9. PubMed ID: 1835913
[TBL] [Abstract][Full Text] [Related]
18. Fibrin formation and platelet aggregation in patients with acute myocardial infarction: effects of intravenous and subcutaneous low-dose heparin.
Gallino A; Haeberli A; Hess T; Mombelli G; Straub PW
Am Heart J; 1986 Aug; 112(2):285-90. PubMed ID: 2426934
[TBL] [Abstract][Full Text] [Related]
19. Platelet activation in response to phlebotomy. An experimental study of healthy blood donors.
Eriksson KA; Sigvaldason A; Lindholm A; Safai-Kutti S; Kutti J
Acta Med Scand; 1982; 212(3):121-3. PubMed ID: 6183925
[TBL] [Abstract][Full Text] [Related]
20. Detection of enhanced in vivo platelet alpha-granule release in different patient groups--comparison of beta-thromboglobulin, platelet factor 4 and thrombospondin assays.
Lane DA; Ireland H; Wolff S; Ranasinghe E; Dawes J
Thromb Haemost; 1984 Oct; 52(2):183-7. PubMed ID: 6084323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
